| Date | Title | | | 05/09/13 | ACETO Board of Directors Declares Quarterly Cash Dividend| PORT WASHINGTON, N.Y., May 9, 2013 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of Directors has declared a regular quarterly dividend of $0.055 per common share. This quarterly cash dividend will be distributed on June 25, 2013 to shareholders of record as of June 14, 2013.
ABOUT ACETO
ACETO Corporation, incorp... |
|  | | 05/09/13 | ACETO Reports Record Fiscal 2013 Third Quarter Net Sales and Gross Profit| FISCAL 2013 THIRD QUARTER HIGHLIGHTS (Comparisons to FY 2012 Q3):
Net sales increased 24.3% to $150.9 million, a record level
Gross profit increased 42.3% to $31.5 million, a record level
Non-GAAP net income increased 92.3% to $9.3 million
Reported GAAP net income increased 41.2% to $7.6 million
Non-GAAP EPS increased 88.9% to $0.34
Reported GAAP EPS increased 40.0% to $0.28
PORT WASHINGTON, N.Y., May 9, 2013 (GLOBE NEWSWIRE) -- ACETO Corporation (Nas... |
|  | | 04/26/13 | ACETO Corporation Schedules Fiscal 2013 Third Quarter Financial Results News Release and Conference Call| PORT WASHINGTON, N.Y., April 26, 2013 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that it will issue its financial results of operations for its fiscal 2013 third quarter ended March 31, 2013 after the stock market closes on Thursday, May 9, 2013. On Friday, May 10, 2013 at 9:00 a.m. ET, the Company will conduct a conference call to ... |
|  | | 04/24/13 | ACETO Announces Management Transition at Its Rising Pharmaceuticals Subsidiary| PORT WASHINGTON, N.Y., April 24, 2013 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, announced today that Ronald Gold and David Rosen, former owners of the Rising Pharmaceuticals business acquired by ACETO in December 2010, informed the Company that they intend to pursue other opportunities apart from ACETO upon the expiration of their three-year emplo... |
|  | | 02/07/13 | ACETO Reports Fiscal 2013 Second Quarter Results|
FISCAL 2013 SECOND QUARTER HIGHLIGHTS (Comparisons to FY 2012 Q2):
Net sales increased 2.9% to $114.0 million, from $110.7 million
Gross profit of $20.7 million, in line with a year ago
Net income of $4.5 million, in line with a year ago
EPS of $0.17, in line with a year ago
PORT WASHINGTON, N.Y., Feb. 7, 2013 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutic... |
|  | | 02/07/13 | ACETO Board of Directors Declares Quarterly Cash Dividend| PORT WASHINGTON, N.Y., Feb. 7, 2013 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that its Board of Directors has declared a regular quarterly dividend of $0.055 per common share. This quarterly cash dividend will be distributed on March 26, 2013 to shareholders of record as of March 15, 2013.
ABOUT ACETO
ACETO Corporation, inc... |
|  | | 01/24/13 | ACETO Corporation Schedules Fiscal 2013 Second Quarter Financial Results News Release and Conference Call| PORT WASHINGTON, N.Y., Jan. 24, 2013 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq:ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that it will issue its financial results of operations for its 2013 fiscal second quarter ended December 31, 2012 after the stock market closes on Thursday, February 7, 2013. On Friday, February 8, 2013, at 9:00 a.m. ET, Salvatore Guccione, Ronald Gold a... |
|  |
|